Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$79.4M
| $1.49M | ﹤0.01% |
212,601
+182,921
| +616% | +$1.36M |
2025 Q3
4 quarters
|
|
2452
Capital Bancorp
CBNK
$689M
| $1.49M | ﹤0.01% |
37,938
-43,370
| -53% | -$1.58M |
2025 Q1
6 quarters
|
|
2453
Silicom
SILC
$166M
| $1.49M | ﹤0.01% |
28,412
+17,112
| +151% | +$749K |
2026 Q2
1 quarter
|
|
2454
Middlesex Water
MSEX
$1.1B
| $1.48M | ﹤0.01% |
+28,023
| New | +$1.59M |
2026 Q3
0 quarters
|
|
2455
CALL
Wingstop
WING
$4.3B
| $1.48M | ﹤0.01% |
14,000
-5,300
| -27% | -$657K |
2024 Q4
7 quarters
|
|
2456
Triumph Financial Inc
TFIN
$1.43B
| $1.47M | ﹤0.01% |
+24,549
| New | +$1.78M |
2026 Q3
0 quarters
|
|
2457
AMC Global Media
AMCX
$391M
| $1.47M | ﹤0.01% |
+125,675
| New | +$1.44M |
2026 Q3
0 quarters
|
|
2458
Oceaneering
OII
$3.55B
| $1.46M | ﹤0.01% |
+33,425
| New | +$1.59M |
2026 Q3
0 quarters
|
|
2459
iShares U.S. Thematic Rotation Active ETF
THRO
$7.31B
| $1.45M | ﹤0.01% |
33,008
-47,666
| -59% | -$2.07M |
2025 Q3
4 quarters
|
|
2460
Vanguard Morningstar Growth ETF
VUG
$219B
| $1.45M | ﹤0.01% |
16,100
-22,052
| -58% | -$1.93M |
2023 Q3
12 quarters
|
|
2461
PUT
Teradyne
TER
$39B
| $1.44M | ﹤0.01% |
3,600
+500
| +16% | +$184K |
2024 Q4
7 quarters
|
|
2462
ProShares UltraShort S&P500
SDS
$405M
| $1.43M | ﹤0.01% |
+26,294
| New | +$1.45M |
2026 Q3
0 quarters
|
|
2463
Schwab US Large-Cap Growth ETF
SCHG
$61.4B
| $1.43M | ﹤0.01% |
39,852
+36,159
| +979% | +$1.27M |
2024 Q1
10 quarters
|
|
2464
First Bank
FRBA
$489M
| $1.42M | ﹤0.01% |
82,635
-5,470
| -6% | -$98.6K |
2025 Q3
4 quarters
|
|
2465
First Financial Corp
THFF
$918M
| $1.42M | ﹤0.01% |
+19,243
| New | +$1.5M |
2026 Q3
0 quarters
|
|
2466
Caribou Biosciences
CRBU
$39.1M
| $1.42M | ﹤0.01% |
1,119,690
+573,935
| +105% | +$897K |
2025 Q3
4 quarters
|
|
2467
Cerus
CERS
$402M
| $1.42M | ﹤0.01% |
597,148
+509,902
| +584% | +$1.4M |
2026 Q2
1 quarter
|
|
2468
DELISTED
Bowman Consulting
BWMN
| $1.41M | ﹤0.01% |
32,994
-21,244
| -39% | -$764K |
2025 Q4
3 quarters
|
|
2469
Hope Bancorp
HOPE
$1.66B
| $1.41M | ﹤0.01% |
105,840
-48,065
| -31% | -$666K |
2026 Q1
2 quarters
|
|
2470
Core Scientific Inc Tranche 1 Warrants
CORZW
$774M
| $1.4M | ﹤0.01% |
152,336
| – | – |
2024 Q1
10 quarters
|
|
2471
Henry Schein
HSIC
$9.5B
| $1.4M | ﹤0.01% |
+16,704
| New | +$1.46M |
2026 Q3
0 quarters
|
|
2472
Banner Corp
BANR
$2.53B
| $1.4M | ﹤0.01% |
20,883
-414,415
| -95% | -$29.1M |
2025 Q3
4 quarters
|
|
2473
Chemung Financial Corp
CHMG
$410M
| $1.4M | ﹤0.01% |
+17,280
| New | +$1.39M |
2026 Q3
0 quarters
|
|
2474
CALL
NRG Energy
NRG
$20.4B
| $1.4M | ﹤0.01% |
14,600
+11,500
| +371% | +$1.39M |
2024 Q4
7 quarters
|
|
2475
ICU Medical
ICUI
$4.48B
| $1.4M | ﹤0.01% |
+8,698
| New | +$1.44M |
2026 Q3
0 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.